Trademark Overview
On Tuesday, January 22, 2008, a trademark application was filed for THERAKIT with the United States Patent and Trademark Office. The USPTO has given the THERAKIT trademark a serial number of 77377345. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Wednesday, July 1, 2009. This trademark is owned by TheraGenetics Limited. The THERAKIT trademark is filed in the Computer & Software Services & Scientific Services and Medical & Beauty Services & Agricultural Services categories with the following description:
Advisory services relating to diagnostic preparations and products, namely, consulting and advisory services relating to the provision of goods containing reagents for use in the collection and testing of DNA, RNA and bodily tissues; advisory services relating to diagnostic apparatus and diagnostic instruments, namely, in connection with assays or assay kits for use in the collection and testing of DNA, RNA and bodily tissues; design and control of pharmacogenetic diagnostic tests for disorders and diseases of the central nervous system; design and control of pharmacogenetic diagnostic tests for psychiatric diseases and disorders; scientific research related to pharmacogenetics; research and advisory services relating to pharmaceuticals
Diagnostic testing relating to the human body, namely, diagnostic testing and analysis of samples to predict response of individuals to pharmaceutical products and treatments for disorders of the central nervous system; diagnostic testing relating to the human body, namely, diagnostic testing and analysis of samples to predict response of individuals to pharmaceutical products and treatments for psychiatric disorders; diagnostic testing relating to the human body, namely, diagnostic testing and analysis of samples to confirm diagnosis of diseases and disorders of the central nervous system; diagnostic testing relating to the human body, namely, diagnostic testing and analysis of samples to confirm diagnosis of psychiatric diseases and disorders; clinical services, namely, analysis of samples of DNA, RNA and bodily tissues to prescribe the most efficient and/or efficacious pharmaceutical product to the patient; medical clinical services, namely, the taking of samples of bodily tissues f...